Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

51.40
Delayed Data
As of Aug 18
 -0.60 / -1.15%
Today’s Change
38.30
Today|||52-Week Range
62.95
-4.73%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close52.00
Today’s open51.55
Day’s range51.20 - 51.90
Volume196,401
Average volume (3 months)273,819
Market cap$1.7B
Dividend yield--
Data as of 4:02pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+7.40%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+13.23%
P/E ratio17.5
Price/Sales3.63
Price/Book4.10

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.08-0.55%
ARRYArray Biopharma Inc-0.01-0.11%
RGENRepligen Corp+0.50+1.26%
LXRXLexicon Pharmaceutic...-0.35-2.44%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts